Business
LiquiBand US Marketing Deal
LiquiBand US Marketing Deal.
About this update from Advanced Medical Solutions Group Plc
[{"type":"text","content":"\n RNS Number : 2358G Advanced Medical Solutions Grp PLC 28 January 2010 \n \n\n\n\n\nFor Immediate Release \n\n\n 28 January 2010\n\n\n\n\n\nAdvanced Medical Solutions Group plc\n(\"AMS\" or \"the Company\")\n\nCardinal Health to distribute LiquiBand™ in US\n\nWinsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, today announces that Cardinal Health (NYSE: CAH), a major US healthcare services company, is marketing and distributing AMS's LiquiBand™ topical skin adhesive range in the US to hospitals, care centres, and surgeries. Cardinal Health has already commenced sales of approved LiquiBand™ products following training of its sales force by AMS.\n\nCardinal Health's appointment is in line with AMS's strategy of forming multiple partnerships for the commercialisation of LiquiBand™. In July last year, AMS announced a partnership with Stryker Corporation (NYSE: SYK) for global marketing and distribution of certain of its LiquiBand™ wound closure products in cranio-maxillofacial surgical procedures. These products are on sale in Europe and awaiting approval in the US.\n\nIn Europe, LiquiBand™ has already established itself as a leading topical skin adhesive range for closing trauma and surgical wounds. LiquiBand™ was initially introduced in the UK in 1999 and is distributed in all of the main markets throughout Europe.\n\nCardinal Health has a substantial US sales force, with 84 surgical speciality, 196 acute care and 285 ambulatory care sales people. These sales people will access the two key segments of the tissue adhesives market in the US: acute care, comprising over 3000 hospitals and attached care centres representing 80% of this market; and alternate site, comprising over 320 surgery centres and 6000 alternate site settings representing 20% of this market.\n\n510(k) approval was received from the Food & Drug Administration (FDA) in February 2009 for the initial LiquiBand™ product line, allowing its sale&n...